Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Typhimurium O-antigen polysaccharide (O4) is a specific structural component of the outer membrane lipopolysaccharide (LPS) of Salmonella enterica serovar Typhimurium. It is a key determinant in bacterial serotyping, immune recognition, and vaccine development. It consists of a repeating tetrasaccharide unit with a Man-Rha-Gal backbone and a unique dideoxyhexose sugar, abequose, which defines the O4 specificity. Antibodies targeting this epitope are crucial for protective immunity against infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Typhimurium O-antigen polysaccharide (O4) (O4 antigen).